| Dr Chris Grayling, DC | |
|
929-a, Highway 59, Anderson, Mo 64831, Anderson, MO 64831-8203 | |
| (417) 226-2225 | |
| Not Available |
| Full Name | Dr Chris Grayling |
|---|---|
| Gender | Female |
| Speciality | Chiropractor |
| Location | 929-a, Highway 59, Anderson, Mo 64831, Anderson, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174095665 | NPI | - | NPPES |
| 230064885 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 2004033158 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chris Grayling, DC Po Box 5241, Bella Vista, AR 72714-0241 Ph: (417) 291-4094 | Dr Chris Grayling, DC 929-a, Highway 59, Anderson, Mo 64831, Anderson, MO 64831-8203 Ph: (417) 226-2225 |
News Archive
"Aid agencies say water and food provision has improved in four camps housing more than 105,000 refugees from Sudan's Blue Nile State, but flooding, disease and an influx of additional refugees pose new threats," IRIN reports, noting, "Sudan's government forces and rebels have been fighting in Blue Nile State since September 2011, sending refugees south."
In a major effort to speed treatment and cures for pediatric brain tumors and cancer, the Children's Brain Tumor Foundation (CBTF) today launched the initial phase of a tissue bank consortium designed to jump-start meaningful analyses that could lead to treatment and cures for these types of cancer, where survival rates are unacceptably low and neurocognitive and other damage is posed by today's treatment options.
While much about Alzheimer's disease remains a mystery, scientists do know that part of the disease's progression involves a normal protein called tau, aggregating to form ropelike inclusions within brain cells that eventually strangle the neurons.
A study based at The University of Texas Health Science Center at Houston provides added justification that a thiazide-type diuretic is the best first-choice drug for hypertensive patients. The findings, published in the American Heart Association's Circulation, Volume 117, Issue 20, evaluate the results of a previous trial coordinated by researchers at The University of Texas School of Public Health, along with other recent studies.
A pair of molecular signals controls skin and hair color in mice and humans — and could be targeted by new drugs to treat skin pigment disorders like vitiligo, according to a report by scientists at NYU Langone Medical Center.
› Verified 1 days ago